Phreesia ROA 2019-2026 | PHR
Current and historical return on assets (ROA) values for Phreesia (PHR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Phreesia ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-04-30 | $0.01B | $0.54B | 1.67% |
| 2026-01-31 | $0.00B | $0.47B | 0.42% |
| 2025-10-31 | $-0.01B | $0.41B | -1.23% |
| 2025-07-31 | $-0.02B | $0.39B | -5.85% |
| 2025-04-30 | $-0.04B | $0.38B | -11.01% |
| 2025-01-31 | $-0.06B | $0.38B | -15.49% |
| 2024-10-31 | $-0.08B | $0.37B | -22.43% |
| 2024-07-31 | $-0.10B | $0.37B | -27.32% |
| 2024-04-30 | $-0.12B | $0.36B | -32.94% |
| 2024-01-31 | $-0.14B | $0.36B | -38.36% |
| 2023-10-31 | $-0.15B | $0.36B | -40.31% |
| 2023-07-31 | $-0.15B | $0.37B | -41.89% |
| 2023-04-30 | $-0.16B | $0.39B | -42.15% |
| 2023-01-31 | $-0.18B | $0.41B | -42.62% |
| 2022-10-31 | $-0.18B | $0.44B | -41.44% |
| 2022-07-31 | $-0.18B | $0.48B | -37.74% |
| 2022-04-30 | $-0.16B | $0.51B | -30.89% |
| 2022-01-31 | $-0.12B | $0.53B | -21.92% |
| 2021-10-31 | $-0.08B | $0.49B | -16.06% |
| 2021-07-31 | $-0.05B | $0.44B | -11.25% |
| 2021-04-30 | $-0.03B | $0.35B | -9.24% |
| 2021-01-31 | $-0.03B | $0.25B | -10.95% |
| 2020-10-31 | $-0.02B | $0.21B | -11.25% |
| 2020-07-31 | $-0.02B | $0.16B | -11.32% |
| 2020-04-30 | $-0.08B | $0.16B | -51.96% |
| 2020-01-31 | $-0.09B | $0.12B | -76.99% |
| 2019-07-31 | $-0.10B | $0.04B | -242.94% |
| 2019-04-30 | $-0.04B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.490B | $0.481B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |